Physician profile
Patrick J Sullivan
NPI 1972024594
$2,795.40
in general payments reported to CMS, 2019-2025
13 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,741 · 2022: $842 · 2024: $110 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $110 · Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $109.98 |
| Food and Beverage | $103.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $841.42 | 2021-2022 | |
| Lilly USA, LLC | $489.94 | 2021-2025 | Mounjaro |
| Abbott Laboratories | $298.86 | 2021-2024 | Freestyle Copilot |
| Sanofi-Aventis U.S. LLC | $212.33 | 2021-2022 | |
| Amgen INC. | $187.56 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $163.36 | 2021-2022 | |
| Dexcom, INC. | $143.95 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $108.26 | 2021 | |
| Tandem Diabetes Care, INC. | $96.67 | 2021-2022 | |
| Corcept Therapeutics | $88.32 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $75.78 | 2021-2022 | |
| Ibsa Pharma INC. | $57.82 | 2021-2022 | |
| Medtronic, INC. | $31.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.